What Happens If a Bipolar Person Doesn’t Take Medication?

Without medication, bipolar disorder tends to follow a pattern of recurring mood episodes that grow harder to manage over time. A systematic review and meta-analysis found that people who stopped their maintenance medication had roughly a 40% higher rate of any mood episode recurring within six months compared to those who stayed on treatment, with manic and hypomanic episodes nearly doubling in likelihood.¹ That said, the picture is more complicated than “stop medication, get sick.” About half of people who discontinued their drugs for six months did not have a recurrence during that window. The question is less whether someone can survive without medication and more about what accumulates when episodes keep coming back unchecked.

How Quickly Episodes Return

The most immediate risk of going without medication is relapse. The meta-analysis mentioned above tracked recurrence at multiple time points and found that staying on medication cut the risk of any mood episode at six months by about 39%, with even stronger protection against manic and hypomanic episodes specifically. That protection held out to at least 24 months. Stopping medication for a month or longer significantly increased the chance of a new episode.¹

A cross-sectional study from Ethiopia found that good medication adherence reduced the odds of relapse by about 61%. The same study noted that longer illness duration, particularly beyond five years, nearly quadrupled the risk of relapse regardless of other factors.² This matters because bipolar disorder is, by nature, a lifelong condition. Before modern mood stabilizers and antipsychotics existed, studies going back two centuries described it as highly recurrent with a poor prognosis. Bipolar patients who had been hospitalized spent roughly a fifth of their lifetime from onset in active mood episodes.³ Modern treatment has not eliminated episodes, but it meaningfully spaces them out and blunts their severity.

Episodes May Become Self-Sustaining Over Time

One of the more concerning ideas in bipolar research is the kindling hypothesis: the notion that early mood episodes are often triggered by major life stressors, but as episodes accumulate, the brain becomes sensitized and starts producing episodes with less and less provocation, or even without any clear external trigger at all.⁴ The evidence for this is mixed. One prospective study found that people with more past episodes did experience more minor stressful events before a depressive episode and more minor positive events before hypomania, but the number of past episodes did not clearly predict how quickly a new episode would start once stress appeared.⁵

Whether or not the full kindling model holds up, there is harder evidence that repeated manic episodes physically change the brain. A large multicenter neuroimaging study of over 1,200 people with bipolar disorder found that more manic and hypomanic episodes were associated with faster thinning of the cortex, especially in the prefrontal areas responsible for planning, impulse control, and emotional regulation.⁶ A narrative review in Molecular Psychiatry reached the same conclusion: manic episodes accelerate decreases in cortical volume and thickness, particularly in the prefrontal cortex. Encouragingly, the same review noted that during stable, episode-free periods, brain structure appeared to stabilize or even partially recover, which underscores why preventing episodes matters so much.⁷

Cognitive Decline With Repeated Episodes

Closely related to the structural brain changes is the question of thinking ability. Cross-sectional research consistently links a higher number of past mood episodes with worse cognitive performance, particularly in executive function, planning, and verbal and visual memory.⁸ Manic episodes seem to be the bigger culprit here. Some cognitive impairment shows up as early as the first manic episode, though patients who remain episode-free afterward can recover a good deal of cognitive function within the first year.⁹

This is a strong argument for early and consistent treatment. Every episode averted is not just relief from the immediate misery of mania or depression. It is potentially preserved cognitive ability in the years and decades ahead. For someone who goes untreated and cycles through many episodes over years, the cumulative effect on memory, concentration, and decision-making can become a practical disability on top of the mood disorder itself.

Suicide Risk

Bipolar disorder carries one of the highest suicide rates of any psychiatric condition, and the relationship between treatment and safety is well established. Clinical trials show that effective treatment of bipolar depression, both in acute episodes and as long-term maintenance, provides strong protection against suicide and suicide attempts.¹⁰ Going without treatment means going without that protective effect. Depressive episodes in bipolar disorder tend to be more prolonged and harder to endure than manic ones, and they are the phase in which suicidal thinking is most likely to intensify. If there is a single reason not to stop medication without a plan, this is it.

Physical Health Consequences

The damage from untreated bipolar disorder is not confined to mood and cognition. The chronic stress of cycling through episodes disrupts the body’s stress-response system and drives up inflammation. This can damage blood vessel walls, promote plaque formation, and increase the risk of blood clots, all of which raise the likelihood of cardiovascular disease.¹¹ People with bipolar disorder already face elevated cardiac risk from genetic factors and, in some cases, from the metabolic side effects of their medications. But uncontrolled mood episodes add a layer of biological stress that compounds the problem. The irony here is real: medication side effects like weight gain are one of the top reasons people stop treatment, yet the disease itself, left unchecked, creates its own set of serious physical health risks.

Work, Money, and Relationships

The toll on daily life is enormous. In a six-year prospective study, 44% of patients with bipolar disorder who were in the workforce at the start ended up receiving a disability pension. Depressive and mixed symptoms were the strongest predictors of losing the ability to work.¹² Longer-term follow-up data paints a similar picture: patients with mood disorders experienced some degree of functional disability during more than half of the months tracked, and people with bipolar I disorder were completely unable to carry out work functions during about 30% of assessed months.¹³

Financial consequences follow from the work disruption but also go beyond it. A study using consumer credit data found that people diagnosed with bipolar I disorder had roughly 50% higher odds of filing for bankruptcy compared to a general population sample.¹⁴ Manic episodes are particularly damaging financially. Impulsive spending sprees, reckless business decisions, and an inflated sense of capability can wreak havoc on savings and credit in a matter of days.

Families absorb a substantial portion of the impact. Research on caregiver burden found that the highest distress came from the patient’s behavior during episodes and from the disruption to work, education, and social relationships. Caregiving for a person with bipolar disorder compromised the caregiver’s own social roles and well-being.¹⁵

Self-Medication With Alcohol and Drugs

When people with bipolar disorder are not on effective treatment, many turn to substances to manage their symptoms on their own. A national epidemiological survey found that about 41% of people with bipolar I disorder reported using alcohol or drugs to relieve mood symptoms, the highest rate among all mood disorders studied.¹⁶ Alcohol might temporarily numb depressive pain or take the edge off anxious restlessness, and stimulants or cannabis might feel like they amplify or stabilize mood. But substance use destabilizes the illness further, disrupts sleep, interferes with any medications the person does take, and creates its own set of dependency and health problems. It is a vicious cycle: untreated episodes drive substance use, which worsens the episodes, which makes treatment harder to re-establish.

Legal Trouble During Mania

Severe manic episodes can lead to behavior that brings people into contact with the criminal justice system. A population-level study found that among people who met criteria for having experienced a manic episode, about 13% reported some form of legal involvement during their most severe episode.¹⁷ This can include arrests for disorderly conduct, trespassing, assault, or erratic driving. Bipolar patients who had been arrested were hospitalized more than three times as frequently per year as those who had not been arrested, suggesting a pattern of revolving-door crises rather than stable community treatment.¹⁸ Criminal records then create cascading problems with employment, housing, and future healthcare access.

How You Stop Matters

Not all medication cessation carries equal risk. The clinical literature draws a sharp line between abrupt discontinuation and gradual tapering. Stopping mood stabilizers suddenly is associated with a faster and more severe relapse than tapering off slowly. Clinicians have increasingly recognized that having a clear discontinuation strategy, rather than simply insisting a patient stay on medication forever, can paradoxically reduce harm. When patients feel trapped in lifelong treatment with no exit plan, some simply stop everything at once, which is the worst-case scenario.¹⁹

There has also been worry that once you stop lithium and relapse, the drug might not work as well when you restart it. The evidence here is reassuring but not definitive. A review of the available studies found mixed results: two studies suggested lithium was less effective after discontinuation and reintroduction, while three found no difference. A pooled analysis did not reach statistical significance for a clear reduction in effectiveness.²⁰ This is good news for people who have lapsed and are considering restarting treatment, though it is not a reason to stop in the first place.

Why People Stop in the First Place

Understanding the risks of going without medication matters more when you understand how common non-adherence is and why it happens. A narrative review identified several key factors:

• Side effects: Weight gain, sedation, dry mouth, tremor, and cognitive dulling are among the most frequent complaints.
• Complexity: Regimens involving multiple medications taken at different times are harder to sustain.
• Poor insight: During well periods, many people feel “cured” and question whether they still need medication. During mania, they may feel better than they ever have and resent anything that dampens that state.
• Substance misuse: Co-occurring alcohol or drug problems make consistent medication use harder.
• Weak treatment relationship: If a patient does not trust or feel heard by their prescriber, adherence drops.

These factors are not character flaws. They are predictable friction points in managing a chronic illness whose very symptoms include impaired judgment and fluctuating motivation.²¹

Pregnancy and Bipolar Medication

One of the most fraught situations is pregnancy. Many women with bipolar disorder taper or stop medication during pregnancy out of concern for the developing baby. This is understandable, but the postpartum period is an extremely high-risk window for relapse, and adequate medication prophylaxis cuts that risk by more than half.²² The dilemma is real: some mood stabilizers carry risks in pregnancy, but so does an untreated mood episode, which can endanger both the mother and the fetus through poor self-care, stress physiology, and erratic behavior.²³ This is a decision that benefits enormously from advance planning with a psychiatrist, ideally before conception.

Can Therapy Alone Replace Medication?

For people who cannot or will not take medication, the question of whether psychotherapy alone can manage bipolar disorder is important. A randomized controlled trial tested Interpersonal and Social Rhythm Therapy (IPSRT), a structured approach that focuses on stabilizing daily routines and sleep-wake cycles, against IPSRT plus the antipsychotic quetiapine in bipolar II depression. About 60% of those receiving therapy alone responded to treatment, rates comparable to what is typically seen with medication. Combining therapy with medication produced somewhat better symptom improvement, but at the cost of more side effects.²⁴ The study had limitations, including high dropout rates and poor remission rates overall, and it focused on bipolar II, which tends to involve less severe mania. For bipolar I, with its full-blown manic episodes, the evidence for therapy alone is much thinner.

Regardless of medication status, sleep is one of the most powerful levers for stability. Experimental evidence shows that sleep deprivation can trigger manic relapse and impair emotion regulation the following day.²⁵ A large study found that sleep loss as a trigger for high mood was especially pronounced in women and in people with bipolar I disorder.²⁶ Protecting sleep through consistent schedules, limiting alcohol and caffeine, and managing shift work is not a substitute for medication, but it is one of the most evidence-supported lifestyle interventions for reducing episode frequency. For anyone weighing whether to stay on or go off medication, sleep hygiene should be the first non-negotiable piece of the plan, not an afterthought.

The Broader Economic Toll

The costs of inadequately treated bipolar disorder ripple well beyond the individual. One estimate put the total annual economic burden of bipolar I disorder in the United States at roughly $219 billion, which breaks down to an average of about $88,000 per person per year. The majority of that, nearly $159 billion, came from indirect costs like lost work productivity and premature death rather than from direct medical spending.²⁷ These numbers reflect a system where many people are undertreated or untreated, and the downstream consequences, including emergency room visits, incarcerations, family disruption, and disability payments, end up costing far more than consistent outpatient care and medication would have. It is one of those frustrating situations where the cheaper and more humane option is also the one that is hardest to deliver at scale.